Skip to the main content.

Cholesterol-Cardiovascular Pathway

MBLI  provides reagents for quantifying PCSK9, which is secretory protein binding to receptor of low-density lipoprotein (LDL) to increase blood levels of LDL cholesterol through suppressing the uptake of LDL cholesterol to liver cells.



Please fill out the following information and click to download the pathway poster.